VNDA is under-performing other Bio-Tech stocks.
Even though I sold 1/3 of my position at 16.51 earlier in the trade, I believe that it is a bad idea to repurchase that position here.
Indeed, I like to add on pull-backs only if EV is not negative, which is not the case for VNDA.
Pascal
Reply With Quote